Nicholas Restifo

Nicholas Restifo

Company: Lyell Immunopharma Inc.

Job title: Cancer immunotherapy Explorer


Enhancing Stemness of Polyclonal T Cells to Improve Anti-Tumor Activity 9:30 am

• Yielding highly effective polyclonal T cell products by utilizing next generation strategies including gene editing • Enriching for tumor-specific T cell clonotypes in clinical T cell products to improve therapeutic efficacy • Emerging approaches to maximize clinical utility of TIL productsRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.